A Study of Tarceva (Erlotinib) in Sequential Combination With Gemcitabine as First Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
Cediranib Versus Placebo Plus Cisplatin/Gemcitabine Chemotherapy for Patients With Advanced Biliary Tract Cancers
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Safety and Tolerability Study of AZD7762 in Combination With Gemcitabine
- Status
- TERMINATED
- Phase
- PHASE1
High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study Of The Effect Of CP-751,871 In Combination With Gemcitabine And Cisplatin In Patients With Advanced Non-Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE3
A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of ABT-263 in Combination With Gemzar (Gemcitabine) in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Tarceva (Erlotinib) or Placebo in Combination With Platinum-Based Therapy as First Line Treatment in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Individualized Treatment Based on Epidermal Growth Factor Receptor Mutations and Level of BRCA1 Expression in Advanced Adenocarcinoma
- Status
- COMPLETED
- Phase
- NA
A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine and Carboplatin for Elderly Patient With Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Participants With Lung Cancer Who Have Not Received Chemotherapy Before
- Status
- COMPLETED
- Phase
- PHASE2
Alimta Plus Gemcitabine for Advanced Sarcoma
- Status
- COMPLETED
- Phase
- PHASE2